DGAP-Media: Girindus AG: Girindus America, Inc. Appoints Dr. Edward Huber as Director - Analytical Development and Quality Control
(firmenpresse) - Girindus AG / Research/Technology
25.05.2010 09:47
Dissemination of a Media Release, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Girindus America, Inc. Appoints Dr. Edward Huber as Director - Analytical
Development and Quality Control
CINCINNATI, Ohio - Girindus, a service provider to the pharmaceutical
industry and a leading manufacturer of therapeutic oligonucleotides, is
pleased to announce the appointment of Dr. Edward Huber as Director -
Analytical Development&QC.
Dr. Huber will provide managerial and technical leadership in the areas of
analytical development and quality control. He brings to Girindus 30 years
of pharmaceutical experience in the area of structural elucidation,
separations sciences, and the development and validation of analytical
methods for the characterization and control of Active Pharmaceutical
Ingredients (API) and finished dosage forms.
'We are very pleased to have Ed on the Girindus leadership team,' said Dr.
Mark Laskovics, Girindus President and COO. 'We welcome his extensive
expertise in both the technical and managerial areas of QC / Analytics
which will reinforce the high quality and technical standards Girindus has
achieved to date'.
Dr. Huber received a BS degree from Xavier University and MS and PhD
Degrees in Analytical Chemistry from the University of Cincinnati. Ed has
demonstrated leadership qualities in both industry and the chemical
community. Dr. Huber has held positions of increasing responsibility in
analytical chemistry at Marion Merrell Dow, Hoechst Marion Roussel, Aventis
and Patheon. He is author or co-author of over 50 scientific publications
in peer-reviewed journals and was most recently Director of Analytical
Development within Patheon's Pharmaceutical Development Services group.
For further information please contact:
Markus Georgi
Head of Investor Relations
Girindus AG, Member of Solvay Organics
phone: +49-2204-926-900
Kathryn L. Ackley, Ph.D.
Director of Operations
Girindus America, Inc, Member of Solvay Organics
phone: +1-513-679-3070
25.05.2010 09:47 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------
Language: English
Company: Girindus AG
Buchenallee 20
51427 Bergisch Gladbach
Deutschland
Internet: www.girindus.com
End of News DGAP-Media
---------------------------------------------------------------------------
Bereitgestellt von Benutzer: EquityStory
" alt="Anglo Canadian Uranium Corp.: Airborne Radiometric and Magnetic Surveys at Yukon Gold Projects
Datum: 25.05.2010 - 09:47 Uhr
Sprache: Deutsch
News-ID 21378
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 257 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-Media: Girindus AG: Girindus America, Inc. Appoints Dr. Edward Huber as Director - Analytical Development and Quality Control"
steht unter der journalistisch-redaktionellen Verantwortung von
Girindus AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
